AI-Assisted Prenatal System for Home & Remote Care—Anywhere. Anytime.

Real-Time Prenatal Scanning at Home
Portable Prenatal Device for Clinics, NGOs, and Moms
AI Risk Detection for Improved Maternal Health
👩⚕️ Clinics & OB/GYNs | 👩 Expecting Women | 🌍 Underserved Populations | 🏥 Health NGOs
DejaVue SUD+ bridges that gap with a safe, stigma-free solution that meets women where they are—at home, in care, or in recovery.
Provisional Patent # 63/840479
$7B+ Global Prenatal Market | 31,000+ Clinics in U.S. | 2,300+ Clinics in California
Pre-Money Valuation: $5M SAFE Note Terms: $250K for a projected 5% equity stake, with a 30% discount at the next priced round.
Projected ROI at Exit ($50M – $100M): 10–20x ROI potential driven by:
Reach out to learn more about DejaVue’s AI ultrasound system, partnership opportunities, clinical pilots, or support for global maternal health.
Your support and contributions will enable us to meet our goals and fund our mission.
Reserve Your Spot – Help Us Bring Prenatal Innovation to Life
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.